Consensus EPS · Q1 2026
$0.93
Consensus revenue · Q1 2026
$1.4B
Analysts
12
Expected report
Apr 23, 2026
Analyst consensus (locked)
Analyst consensus
Based on estimates from 12 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.4B |
| EPS | $0.90 | $0.93 | $0.97 |
| EBITDA | $433.7M | $457M | $470.4M |
| EBIT | $355.2M | $374.3M | $385.2M |
| Net income | $514.7M | $531.9M | $554.7M |
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.4B | $1.4B | +1.7% | $0.96 | $0.92 | +4.2% |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Nasdaq (NDAQ) Q1 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $109.00 | $114.60 | $115.00 | $120.00 | $87.28 | +31.3% |
Upside calculated vs most recent trading price of $87.28.
Analyst ratings
Consensus: Buy — based on 36 analyst ratings.
12-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 24, 2026 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Apr 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 8, 2026 | Barclays | maintain | Overweight | Overweight |
| Feb 26, 2026 | TD Cowen | upgrade | Hold | Buy |
| Jan 30, 2026 | TD Cowen | maintain | Hold | Hold |
| Jan 30, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jan 30, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jan 30, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jan 30, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 15, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
Nasdaq (NDAQ) Key Financials
Charts, filings, and peer comparison for every metric
Frequently asked questions
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation